학술논문

Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
Document Type
Article
Source
In: Breast Cancer Research. (Breast Cancer Research, 15 March 2012, 14(2))
Subject
Language
English
ISSN
14655411
1465542X